National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

HIV/AIDS
 Understanding
 Research
  Basic Science
  Epidemiology
  Prevention
  Therapeutics
  Vaccines
   Introduction and Goals
   Research Activities
    Animal Models
    Assessment
    Designs and Concepts
    Vaccine Clinical Trials
    Glossary
    Pre-clinical Toxicology Testing of Vaccines
   Resources for Researchers
   Funding
   Meetings
   Reports and Articles
   Advisory and Working Groups
   Clinical Trials
   Considerations Papers
   Latest News


HIV/AIDS

Vaccines

Animal Models

No ideal model exists that can imitate the natural history and pathogenesis of HIV infection and AIDS in the human body, as HIV virus exclusively infects and causes disease in humans. Nonetheless, the data from animal models provides conceptual insights into immune responses elicited by investigational vaccines, and reassurance of safety, guiding preclinical development and the decision to enter into clinical trials in humans.

Non-human primate studies play a leading role in efforts to develop an HIV vaccine.

Scientists are using macaque monkeys infected with simian immunodeficiency virus (SIV), a virus closely related to HIV. This model is useful because SIV in macaques follows a similar disease course to HIV, albeit slowly, and adequate numbers of animals are available. A potential shortcoming is that SIV and HIV, although similar, are different viruses, so that advances made with SIV need to be verified using HIV. Macaques are being used to evaluate a variety of SIV vaccines of the same type as HIV vaccines being developed for humans. Because the monkeys can be challenged with SIV after immunization, the vaccines can be evaluated for their ability to protect from virus infection or disease in the monkeys.

A hybrid virus created by replacing SIV envelope with HIV envelope but retaining the inner core of SIV virus (called SHIVs), replicates acute HIV infection in macaques, and causes rapid disease progression leading to death. Monkeys vaccinated with HIV vaccines are challenged with chimeric SHIV to test the ability of the vaccine to protect from infection with the SHIV viruses.

Scientists are also using a number of different animal models to obtain information that can have application to HIV. Feline immunodeficiency virus (FIV), transgenic mice that contain part of the HIV genome or co-receptors for viral entry, and severe combined immune deficiency (SCID) mice reconstituted with human immune system cells or tissues are some of the animal models being used to study pathogenesis.

back to top


Highlights

25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances (Commentary by NIAID Director Anthony S. Fauci published in Cell)—Nov. 2, 2007

See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines
  • E-mail Icon E-mail this page
    Print Icon Print this page
    Plug-ins and Viewers
    To open PDFs on this page, download and install the Adobe Acrobat Reader.

    Highlights

    25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances (Commentary by NIAID Director Anthony S. Fauci published in Cell)—Nov. 2, 2007

    See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines